{"success":true,"data":{"pressRelease":{"id":"150193","rtpr_id":"nBw8qM23La-20260922","ticker":"MEDP","exchange":"NASDAQ","all_tickers":["MEDP"],"title":"Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026","author":"Business Wire","published_at":"2026-09-22T20:05:00.212Z","article_body":"Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on\nOctober 21, 2026\n\nMedpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it\nwill report its third quarter 2026 financial results after the market close on\nWednesday, October 21, 2026. The Company will host a conference call the\nfollowing morning, Thursday, October 22, 2026, at 9:00 a.m. ET to discuss\nthese results.\n\nTo participate in the conference call, interested parties must register in\nadvance by clicking on this link\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fregister-conf.media-server.com%2Fregister%2FBI4dfb23427d8545bd9dfd70da4f293d31&esheet=54608965&newsitemid=20260922363996&lan=en-US&anchor=this+link&index=1&md5=262870238f7979eb582cd0b914df0c94)\n. While it is not required, it is recommended you join 10 minutes prior to the\nevent start. Upon registration, all telephone participants will receive a\nconfirmation email detailing how to join the conference call, including the\ndial-in number along with a unique PIN that can be used to access the call.\n\nTo access the conference call via webcast, visit the “Investors” section\nof Medpace’s website at investor.medpace.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Finvestor.medpace.com%2F&esheet=54608965&newsitemid=20260922363996&lan=en-US&anchor=investor.medpace.com&index=2&md5=816bccaf94973d01fd948b9bf8f41a64)\n. The webcast replay of the call will be available at the same site\napproximately one hour after the end of the call.\n\nA supplemental slide presentation will also be available at the\n“Investors” section of Medpace’s website prior to the start of the call.\n\nAbout Medpace\n\nMedpace is a scientifically-driven, global, full-service clinical contract\nresearch organization (CRO) providing Phase I-IV clinical development services\nto the biotechnology, pharmaceutical and medical device industries.\nMedpace’s mission is to accelerate the global development of safe and\neffective medical therapeutics through its high-science and disciplined\noperating approach that leverages regulatory and therapeutic expertise across\nall major areas including oncology, cardiology, metabolic disease,\nendocrinology, central nervous system and anti-viral and anti-infective.\nHeadquartered in Cincinnati, Ohio, Medpace employs approximately 6,500 people\nacross 46 countries as of June 30, 2026.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260922363996/en/\n(https://www.businesswire.com/news/home/20260922363996/en/)\n\nInvestor Contact:\n\nDavid Ruhe\n\n283-227-6472\n\nd.ruhe@medpace.com (mailto:d.ruhe@medpace.com)\n\nMedia Contact:\n\nMichael Maley\n\n283-227-6367\n\nm.maley@medpace.com (mailto:m.maley@medpace.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw8qM23La-20260922","title":"Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026","author":"Business Wire","ticker":"MEDP","created":"2026-09-22T20:05:00.212Z","tickers":["MEDP"],"exchange":"NASDAQ","article_body":"Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on\nOctober 21, 2026\n\nMedpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it\nwill report its third quarter 2026 financial results after the market close on\nWednesday, October 21, 2026. The Company will host a conference call the\nfollowing morning, Thursday, October 22, 2026, at 9:00 a.m. ET to discuss\nthese results.\n\nTo participate in the conference call, interested parties must register in\nadvance by clicking on this link\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fregister-conf.media-server.com%2Fregister%2FBI4dfb23427d8545bd9dfd70da4f293d31&esheet=54608965&newsitemid=20260922363996&lan=en-US&anchor=this+link&index=1&md5=262870238f7979eb582cd0b914df0c94)\n. While it is not required, it is recommended you join 10 minutes prior to the\nevent start. Upon registration, all telephone participants will receive a\nconfirmation email detailing how to join the conference call, including the\ndial-in number along with a unique PIN that can be used to access the call.\n\nTo access the conference call via webcast, visit the “Investors” section\nof Medpace’s website at investor.medpace.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Finvestor.medpace.com%2F&esheet=54608965&newsitemid=20260922363996&lan=en-US&anchor=investor.medpace.com&index=2&md5=816bccaf94973d01fd948b9bf8f41a64)\n. The webcast replay of the call will be available at the same site\napproximately one hour after the end of the call.\n\nA supplemental slide presentation will also be available at the\n“Investors” section of Medpace’s website prior to the start of the call.\n\nAbout Medpace\n\nMedpace is a scientifically-driven, global, full-service clinical contract\nresearch organization (CRO) providing Phase I-IV clinical development services\nto the biotechnology, pharmaceutical and medical device industries.\nMedpace’s mission is to accelerate the global development of safe and\neffective medical therapeutics through its high-science and disciplined\noperating approach that leverages regulatory and therapeutic expertise across\nall major areas including oncology, cardiology, metabolic disease,\nendocrinology, central nervous system and anti-viral and anti-infective.\nHeadquartered in Cincinnati, Ohio, Medpace employs approximately 6,500 people\nacross 46 countries as of June 30, 2026.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260922363996/en/\n(https://www.businesswire.com/news/home/20260922363996/en/)\n\nInvestor Contact:\n\nDavid Ruhe\n\n283-227-6472\n\nd.ruhe@medpace.com (mailto:d.ruhe@medpace.com)\n\nMedia Contact:\n\nMichael Maley\n\n283-227-6367\n\nm.maley@medpace.com (mailto:m.maley@medpace.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-09-22T20:05:00.261493297Z","server_sent_at_ms":1790107500261},"received_at":"2026-09-22T20:05:00.423Z","source_url":"https://www.businesswire.com/news/home/20260922363996/en/"},"analysis":{"id":"138990","press_release_id":"150193","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Medpace Holdings will report third quarter 2026 financial results after the market close on Wednesday, October 21, 2026.\n\nA conference call to discuss the results will be held the following morning, October 22, at 9:00 a.m. ET, with registration required for telephone participants and a webcast available at investor.medpace.com.\n\nMedpace is a Cincinnati-based full-service clinical CRO employing approximately 6,500 people across 46 countries as of June 30, 2026.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Calendar note only -- Q3 2026 earnings scheduled for October 21 after the close."},"keyFigures":{},"namedEntities":{"people":[{"name":"David Ruhe","role":"Investor Contact"},{"name":"Michael Maley","role":"Media Contact"}],"products":[],"companies":[{"name":"Medpace Holdings, Inc.","ticker":"MEDP"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine earnings-date announcement with no financial figures, guidance, or corporate actions. Pure scheduling/boilerplate."},"tickerRelevance":{"others":[],"primary":"MEDP"},"globalImportance":5,"audienceRelevance":20,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"earnings-date-announcement","issuerAuthored":true}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Medpace Holdings will report third quarter 2026 financial results after the market close on Wednesday, October 21, 2026.\n\nA conference call to discuss the results will be held the following morning, October 22, at 9:00 a.m. ET, with registration required for telephone participants and a webcast available at investor.medpace.com.\n\nMedpace is a Cincinnati-based full-service clinical CRO employing approximately 6,500 people across 46 countries as of June 30, 2026.","key_figures":{},"named_entities":{"people":[{"name":"David Ruhe","role":"Investor Contact"},{"name":"Michael Maley","role":"Media Contact"}],"products":[],"companies":[{"name":"Medpace Holdings, Inc.","ticker":"MEDP"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-22T20:05:04.347Z","global_importance":5,"audience_relevance":20,"importance_components":{"tickerTier":"mid-cap","eventGravity":"earnings-date-announcement","issuerAuthored":true}},"durationMs":3911,"modelName":"glm-5.3-flashx"}}